Lexicon Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.45 | -$0.05 | -$0.18 |
| Q2 2024 | 1 | -$0.44 | -$0.05 | -$0.18 |
| Q3 2024 | 1 | -$0.40 | -$0.05 | -$0.16 |
| Q4 2024 | 4 | -$0.15 | -$0.07 | -$0.13 |
| Q1 2025 | 2 | -$0.16 | -$0.14 | -$0.15 |
| Q2 2025 | 1 | -$0.37 | -$0.04 | -$0.15 |
| Q3 2025 | 1 | -$0.37 | -$0.04 | -$0.15 |
| Q4 2025 | 1 | -$0.35 | -$0.04 | -$0.14 |
| Q1 2026 | 1 | -$0.40 | -$0.05 | -$0.16 |
| Q2 2026 | 1 | -$0.40 | -$0.05 | -$0.16 |
| Q3 2026 | 1 | -$0.40 | -$0.05 | -$0.16 |
| Q4 2026 | 1 | -$0.42 | -$0.05 | -$0.17 |
Lexicon Pharmaceuticals, Inc. Earnings Date And Information
Lexicon Pharmaceuticals, Inc. last posted its earnings results on Thursday, August 1st, 2024. The company reported $-0.17 earnings per share for the quarter, topping analysts' consensus estimates of $-0.18 by $0.01. The company had revenue of 1.74 M for the quarter and had revenue of 1.20 M for the year. Lexicon Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-0.8 diluted earnings per share) and currently has a price-to-earnings ratio of -1.78. Lexicon Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Lexicon Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.18 | $2.99 M | $1.74 M | ||
| 08/02/2024 | Q2 2024 | -$0.17 | $3.44 M | $1.65 M | ||
| 05/02/2024 | Q1 2024 | -$0.18 | -$0.20 | -0.02 | $1.13 M | |
| 03/25/2024 | Q4 2023 | -$0.20 | $702,000 | |||
| 11/08/2023 | Q3 2023 | -$0.22 | -$0.21 | 0.01 | $2.06 M | $162,000 |
| 08/04/2023 | Q2 2023 | -$0.22 | $66,667 | $317,000 | ||
| 05/04/2023 | Q1 2023 | -$0.16 | $24,000 | |||
| 03/03/2023 | Q4 2022 | -$0.16 | $28,000 | |||
| 11/09/2022 | Q3 2022 | -$0.15 | -$0.14 | 0.01 | $50,000 | $39,000 |
| 08/03/2022 | Q2 2022 | -$0.17 | $100,000 | $35,000 | ||
| 05/05/2022 | Q1 2022 | -$0.16 | -$0.16 | 0 | $37,000 | |
| 03/10/2022 | Q4 2021 | -$0.17 | $14,000 | |||
| 11/09/2021 | Q3 2021 | -$0.16 | $23,000 | |||
| 08/06/2021 | Q2 2021 | -$0.13 | $13,500 | $234,000 | ||
| 05/06/2021 | Q1 2021 | -$0.17 | -$0.15 | 0.02 | $27,000 | |
| 03/12/2021 | Q4 2020 | -$0.04 | $199,000 | |||
| 10/30/2020 | Q3 2020 | $0.77 | $91.34 M | $6.63 M | ||
| 07/29/2020 | Q2 2020 | -$0.65 | $8.84 M | $9.16 M | ||
| 04/27/2020 | Q1 2020 | -$0.66 | -$0.63 | 0.03 | $8.00 M | |
| 03/12/2020 | Q4 2019 | -$0.76 | -$0.48 | 0.28 | $8.73 M |
Lexicon Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Lexicon Pharmaceuticals, Inc.'s earnings date?
Lexicon Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
Did Lexicon Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Lexicon Pharmaceuticals, Inc. (:LXRX) reported $-0.17 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.18 by $0.01.
-
How can I listen to Lexicon Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Lexicon Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Lexicon Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Lexicon Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Lexicon Pharmaceuticals, Inc. generate each year?
Lexicon Pharmaceuticals, Inc. (:LXRX) has a recorded annual revenue of $1.20 M.
-
How much profit does Lexicon Pharmaceuticals, Inc. generate each year?
Lexicon Pharmaceuticals, Inc. (:LXRX) has a recorded net income of $1.20 M. Lexicon Pharmaceuticals, Inc. has generated $-0.8 earnings per share over the last four quarters.
-
What is Lexicon Pharmaceuticals, Inc.'s price-to-earnings ratio?
Lexicon Pharmaceuticals, Inc. (:LXRX) has a price-to-earnings ratio of -1.78 and price/earnings-to-growth ratio is -0.46.
